Back to search
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome trials you may qualify forThis MyeloMATCH Master Screening and Reassessment Protocol (MSRP) evaluates the use of a screening tool and specific laboratory tests to help improve participan…
This phase II MyeloMATCH treatment trial tests whether the standard approach of cytarabine and daunorubicin in comparison to the following experimental regimens…
This phase I/II trial studies the side effects and best dose of a radioactive agent linked to an antibody (211At-BC8-B10) followed by donor stem cell transplant…
This phase I trial studies the side effects and best dose of ruxolitinib when given together with venetoclax and compares the effect of ruxolitinib in combinati…
This trial is evaluating the safety and tolerability of venetoclax with chemotherapy in pediatric and young adult patients with hematologic malignancies, includ…
This phase I trial studies the side effects and best dose of edetate calcium disodium or succimer in treating patients with acute myeloid leukemia or myelodyspl…
This phase II trial studies how well cytarabine and idarubicin or daunorubicin with or without pembrolizumab work in treating patients with newly-diagnosed acut…
This phase II MyeloMATCH treatment trial compares cytarabine versus (vs.) cytarabine and venetoclax vs. liposome-encapsulated daunorubicin-cytarabine and veneto…